Stockreport

Quoin Pharmaceuticals Announces Opening Of First Clinical Site For Netherton Syndrome Clinical Study [TheStreet.com]

Quoin Pharmaceuticals, Ltd. - American Depositary Shares  (QNRX) 
PDF ASHBURN, Va., July 06, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. ( ) (the "Company" or "Quoin"), a specialty pharmaceutical company focused on rare and orphan [Read more]